Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1/2 multicenter clinical trial of SCID gene therapy

Next Previous
X
Search
Trial Profile

Phase 1/2 multicenter clinical trial of SCID gene therapy

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Aug 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SCID gene therapy-Mustang Bio (Primary)
  • Indications Immunodeficiency disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 27 Jul 2022 According to a Mustang Bio media release, first patient has been treated.
    • 23 Nov 2021 New trial record
    • 10 Nov 2021 According to an Mustang Bio media release, trial recently enrolled first patient and additional clinical sites are expected to be added in the near future.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top